About the Annual Advancement in Equine Research Award

Boehringer Ingelheim will provide five $15,000 awards to the winning proposals for equine infectious disease research. Veterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine infectious disease(s). Winning proposals will be selected by an independent review board.

Our independent Equine Research Review Board members look forward to reviewing your proposals.

  • Objectives

    1. To provide a venue for Boehringer Ingelheim to sponsor equine disease research for the benefit of the equine industry
    2. To encourage interaction among equine researchers and practitioners
    3. To enhance knowledge and communication of new information to the industry
    4. To reward research excellence
  • Components of the Advancement in Equine Research Award

    The Annual Equine Research Award consists of five separate U.S. $15,000 awards focused on a specific disease topic. The 2017 research topic Equine Infectious Disease with suggested areas of research focused on:

    a. Practical application and ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease(s)

    b. Disease(s) can be bacterial or viral etiologics

    Following publication acceptance of the three awarded research projects, the Independent Review  Board will perform a second review of manuscripts for quality and designate additional awards:

    • 1st award $5,000
    • 2nd award $3,000
    • 3rd award $1,000
  • Eligibility for Participation

    • Students 
    • Researchers 
    • Diagnosticians 
    • Animal Scientists 
    • Practitioners

    Eligibility for participation to include anyone in United States, Canada and Mexico. 

  • Basic Requirements for Proposal

    • Research must have the potential to generate new information that has clear relevance to the designated research topic
    • The proposal must have a timeline including start date and completion date (maximum 12 months  following initial funding)
    • The proposal should target an oral presentation at the American Association of Equine Practitioners Annual Convention upon completion
    • Application must comply with the format provided by the Advancement in Equine Research  Review Board
  • Selection Criteria

    The Advancement in Equine Research Review Board acting on its own, without influence from the sponsoring company, will peer review and select proposals based on the following criteria:

    • Probability of successfully completing the project
    • Potential for impact to the equine industry
    • Originality
    • Scientific quality
  • The Advancement in Equine Research Review Board Members

    The independent Review Board has revolving seats to ensure the Board remains impartial and infused with new ideas. The renowned members consist of equine industry professionals including practicing veterinarians and researchers.

    • Tom Divers, DVM, DACVIM, DACVECC
    • Rob Franklin, DVM, DACVIM
    • Debra Sellon, DVM, PhD, DACVIM
    • Nathan Slovis, DVM, DACVIM, CHT
    • Julie Wilson, DVM, DACVIM
  • Confidentiality of Proposals

    • The Board agrees not to discuss proposals outside the venue
    • The Board members have signed a confidentiality agreement regarding information disclosure, which will be provided upon request
    • Boehringer Ingelheim Vetmedica personnel, who will manage the practical collection of proposals, will comply with the same level of confidentiality as the Board members
  • Board Member Conflict of Interest

    Board members will not participate in the review and evaluation of any proposals or subsequent manuscripts for which they are investigators or authors, respectively.

  • Application Procedure

    The application must comply with the application form provided by the Advancement of Equine Research Review Board. The form may be obtained from Boehringer Ingelheim, 3902 Gene Field Rd., St. Joseph, MO 64506, Attn: Dr. Steve Grubbs, or request through e-mail at steve.grubbs@boehringer-ingelheim.com, or by clicking here.

    Submit Your Application to:

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Dr. Steve Grubbs
    The Advancement in Equine Research - 2017
    3902 Gene Field Rd.
    St. Joseph, MO 64506

Proposals Due 

The deadline for proposals for the 2017 Advancement in Equine Research Award is: September 15, 2017

Submit Your Proposal To:

  • The 2017 Advancement in Equine Research Award

    Boehringer Ingelheim 
    Attn: Dr. Steve Grubbs
    3902 Gene Field Road
    St. Joseph, Missouri 64506

    Mark the envelope “The Advancement in Equine Research Award”

Contact Us

  • The Advancement in Equine Research Award

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Dr. Steve Grubbs
    3902 Gene Field Road
    St. Joseph, Missouri 64506